beta-2 Microglobulin antibody (APC)

Catalog No. ABIN2656877

This anti-beta-2 Microglobulin antibody is a Mouse Monoclonal antibody detecting beta-2 Microglobulin in FACS and CyTOF. Suitable for Human.

Quick Overview for beta-2 Microglobulin antibody (APC) (ABIN2656877)

Target: beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This beta-2 Microglobulin antibody is conjugated to APC

Application: Flow Cytometry (FACS), Cytometry by Time of Flight (CyTOF)

Clone: 2M2

Product Details anti-beta-2 Microglobulin Antibody (APC)

Cross-Reactivity: Pig (Porcine)

Purification: The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions. The solution is free of unconjugated APC and unconjugated antibody.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C

Target Details for beta-2 Microglobulin

Target: beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

Alternative Name: Beta2-Microglobulin

Background: β2-microglobulin (β2M) is a 12 kD nonpolymorphic Ig like protein. It is a non-membrane-anchored glycoprotein and is noncovalently associated with 39-44 kD polymorphic heavy chains of MHC class I molecules to form HLA class I antigen complex. In association with HLA class I, β2M is expressed on all leukocytes, platelets, endothelial cells and epithelial cells. β2M plays an essential role both in governing MHC class I molecules' stability and in promoting antigen binding and presenting the antigen to CD3/TCR complex of CD8+ T cells.

Pathways: TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process